Purchase Warrant Sample Contracts

Cambridge Holdco Corp. – Ordinary Share Purchase Warrant Ability Inc. (October 29th, 2018)

THIS ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on [___]1 (the "Termination Date"), but not thereafter, to subscribe for and purchase from Ability Inc., a Cayman Islands company (the "Company"), up to ______ Ordinary Shares, $0.001 par value (the "Ordinary Share(s)") (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Registration Statement which Registration Statement also registers the Warrant Shares issuable upon exercise of this Warrant.

Cambridge Holdco Corp. – Placement Agent Ordinary Share Purchase Warrant Ability Inc. (October 29th, 2018)

THIS ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on [___]1 (the "Termination Date"), but not thereafter, to subscribe for and purchase from Ability Inc., a Cayman Islands company (the "Company"), up to ______ Ordinary Shares, $0.001 par value (the "Ordinary Share(s)") (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Registration Statement which Registration Statement also registers the Warrant Shares issuable upon exercise of this Warrant. This Warrant is issued pursuant to that certain Engagement Agre

Cambridge Holdco Corp. – Placement Agent Ordinary Share Purchase Warrant Ability Inc. (October 29th, 2018)

THIS ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, [___] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August 16, 2018 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on August 14, 2018 (the "Termination Date") but not thereafter, to subscribe for and purchase from Ability Inc., a Cayman Islands company (the "Company"), up to [___] Ordinary Shares, $0.001 par value (the "Ordinary Share(s)") (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of August 6, 2018.

Cambridge Holdco Corp. – Pre-Funded Ordinary Share Purchase Warrant Ability Inc. (October 29th, 2018)

THIS PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") until this Warrant is exercised in full (the "Termination Date"), to subscribe for and purchase from Ability Inc., a Cayman Islands company (the "Company"), up to ______ Ordinary Shares, $0.001 par value (the "Ordinary Share(s)") (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Registration Statement which Registration Statement also registers the Warrant Shares issuable upon exercise of this Warrant.

JUMP WORLD HOLDINGS Ltd – Ordinary Share Purchase Warrant Jump World Holding Limited (October 19th, 2018)

THIS ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, Boustead Securities, LLC, the registered holder hereof or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _______, 201__, being any date after the issuance of this Warrant(the "Initial Exercise Date") and on or prior to the close of business on the three (3) year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from JUMP WORLD HOLDING LIMITED, a Cayman Islands exempted company (the "Company"), up to [ ] Ordinary Shares1 (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Common Share Purchase Warrant Intellipharmaceutics International Inc. (October 11th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on ______________1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Intellipharmaceutics International Inc., a Canadian corporation (the "Company"), up to ______ Common Shares (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Registration Statement which Registration Statement also registers the Warrant Shares issuable upon exercise of this Warrant.

Pre-Funded Common Share Purchase Warrant Intellipharmaceutics International Inc. (October 11th, 2018)

THIS PRE-FUNDED COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and until this Warrant is exercised in full (the "Termination Date"), to subscribe for and purchase from Intellipharmaceutics International Inc., a Canadian corporation (the "Company"), up to ______ Common Shares (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Registration Statement which Registration Statement also registers the Warrant Shares issuable upon exercise of this Warrant.

Underwriter Common Share Purchase Warrant Intellipharmaceutics International Inc. (October 11th, 2018)

THIS UNDERWRITER COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on ______________1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Intellipharmaceutics International Inc., a Canadian corporation (the "Company"), up to ______ Common Shares (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Registration Statement which Registration Statement also registers the Warrant Shares issuable upon exercise of this Warrant.

Kinder Holding Corp. – Class E Share Purchase Warrant Nexien Biopharma, Inc. (September 28th, 2018)

THIS CLASS E SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the "Initial Exercise Date") and on or prior to 5:00 p.m. Mountain Time on January 31, 2019 (the "Termination Date") but not thereafter, to subscribe for and purchase from NEXIEN BIOPHARMA, INC., a Delaware corporation (the "Company"), up to ______ shares of Common Stock (the "Warrant Shares"). The purchase price of one Warrant Share shall be equal to the Exercise Price, as defined in Section 1(b).

Kinder Holding Corp. – Class D Unit Purchase Warrant Nexien Biopharma, Inc. (September 28th, 2018)

THIS CLASS D UNIT PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the "Initial Exercise Date") and on or prior to 5:00 p.m. Mountain Time on November 30, 2018 (the "Termination Date") but not thereafter, to subscribe for and purchase from NEXIEN BIOPHARMA, INC., a Delaware corporation (the "Company"), up to ______ Units each such Unit consisting of one share of Common Stock (the "Warrant Shares") and one Class E Common Stock Purchase Warrant (the "Class E Warrants"), which such Class E Warrant shall have an exercise price equal to $2.00 per share and be exercisable through January 31, 2019. The purchase price of one Unit shall be equal to the Exercise Price, as defined in Section 1(b).

JUMP WORLD HOLDINGS Ltd – Ordinary Share Purchase Warrant Jump World Holding Limited (September 26th, 2018)

THIS ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, Boustead Securities, LLC, the registered holder hereof or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _______, 201__, being any date after the issuance of this Warrant (the "Initial Exercise Date") and on or prior to the close of business on the three (3) year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from JUMP WORLD HOLDING LIMITED, a Cayman Islands exempted company (the "Company"), up to [ ] Ordinary Shares1 (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Inmune Bio, Inc. – The Registered Holder of This Purchase Warrant by Its Acceptance Hereof, Agrees That It Will Not Sell, Transfer or Assign This Purchase Warrant Except as Herein Provided and the Registered Holder of This Purchase Warrant Agrees That It Will Not Sell, Transfer, Assign, Pledge or Hypothecate This Purchase Warrant for a Period of One Hundred Eighty Days Following the Effective Date (Defined Below) to Anyone Other Than (I) Univest Securities, Llc or a Sub-Agent or a Selected Dealer in Connection With the Offering, or (Ii) a Bona Fide Officer or Partner of Univest Securities, Llc, or of Any Such Pl (September 26th, 2018)

THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [*], 20[__] [DATE THAT IS 180 DAYS FROM THE EFFECTIVE DATE OF THE REGISTRATION STATEMENT]. VOID AFTER 5:00 P.M., EASTERN TIME, [*], 20[__] [DATE THAT IS FIVE YEARS ANNIVERSARY THEREOF].

Titan Pharmaceuticals – The Registered Holder of This Purchase Warrant by Its Acceptance Hereof, Agrees That It Will Not Sell, Transfer or Assign This Purchase Warrant Except as Herein Provided and the Registered Holder of This Purchase Warrant Agrees That It Will Not Sell, Transfer, Assign, Pledge or Hypothecate This Purchase Warrant for a Period of One Hundred Eighty Days Following the Effective Date (Defined Below) to Anyone Other Than (I) A.G.P./ALLIANCE Global Partners or an Underwriter or a Selected Dealer in Connection With the Offering, or (Ii) a Bona Fide Officer or Partner of A.G.P./ALLIANCE Global Partners (September 12th, 2018)

THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS 5 YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].

Adial Pharmaceuticals, L.L.C. – Form of Unit Purchase Warrant (September 10th, 2018)

THIS CERTIFIES THAT, for value received, ___________________ or his, her or its assigns ("Holder"), is entitled to purchase from Adial Pharmaceuticals, Inc., a Delaware corporation (the "Company"), at any time or from time to time during the period specified in Paragraph 2 hereof and subject to adjustment as provided herein, _________ units (each a "Unit" and collectively, the "Units"), with each Unit consisting of one share of the Company's common stock, par value $0.001 per share (the "Common Stock"), and one warrant (each a "Common Warrant" and collectively, the "Common Warrants") to purchase one share of Common Stock. The form of Common Warrant is attached hereto as Exhibit A. The exercise price per Unit is $5.00 (the "Exercise Price"). The term "Warrant Shares" as used herein, refers to the shares of Common Stock purchasable under this Warrant and the term "Common Warrant Shares" as used herein, refers to the shares of Common Stock purchasable under any Common Warrant that may be

Titan Pharmaceuticals – The Registered Holder of This Purchase Warrant by Its Acceptance Hereof, Agrees That It Will Not Sell, Transfer or Assign This Purchase Warrant Except as Herein Provided and the Registered Holder of This Purchase Warrant Agrees That It Will Not Sell, Transfer, Assign, Pledge or Hypothecate This Purchase Warrant for a Period of One Hundred Eighty Days Following the Effective Date (Defined Below) to Anyone Other Than (I) A.G.P./ALLIANCE Global Partners or an Underwriter or a Selected Dealer in Connection With the Offering, or (Ii) a Bona Fide Officer or Partner of A.G.P./ALLIANCE Global Partners (August 30th, 2018)

THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS 5 YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].

Establishment Labs Holdings Inc. – Establishment Labs Holdings Inc. Amended and Restated Ordinary Share Purchase Warrant (Void After August 28, 2022) (July 13th, 2018)

Notwithstanding anything to the contrary in this Warrant, upon written notice by the Registered Holder to the Company, the Registered Holder shall have the right, but not the obligation, to waive all or any portion of the Registered Holder's rights under this Warrant. This Warrant is being reissued pursuant to and in accordance with the Prior Warrant. Capitalized terms used and not defined herein shall have the meanings ascribed thereto in that certain Note and Warrant Purchase Agreement dated as of August 28, 2015 by and between the Company and CPH TU, LP.

Auris Medical AG – COMMON SHARE PURCHASE WARRANT AURIS MEDICAL Holding Ag (July 12th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on June 18, 2020 (the "Termination Date") but not thereafter, to subscribe for and purchase from Auris Medical Holding AG, a company established in Switzerland (the "Company"), up to [______] (as subject to adjustment hereunder, the "Warrant Shares") of registered common shares, nominal value CHF 0.02 per share (each, a "Common Share"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Auris Medical AG – COMMON SHARE PURCHASE WARRANT AURIS MEDICAL Holding Ag (July 12th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on June 18, 2020 (the "Termination Date") but not thereafter, to subscribe for and purchase from Auris Medical Holding AG, a company established in Switzerland (the "Company"), up to [______] (as subject to adjustment hereunder, the "Warrant Shares") of registered common shares, nominal value CHF 0.02 per share (each, a "Common Share"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Auris Medical AG – COMMON SHARE PURCHASE WARRANT AURIS MEDICAL Holding Ag (July 12th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on [_______]1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Auris Medical Holding AG, a company established in Switzerland (the "Company"), up to [______] (as subject to adjustment hereunder, the "Warrant Shares") of registered common shares, nominal value CHF 0.02 per share (each, a "Common Share"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Auris Medical AG – COMMON SHARE PURCHASE WARRANT AURIS MEDICAL Holding Ag (July 3rd, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on [_______]1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Auris Medical Holding AG, a company established in Switzerland (the "Company"), up to [______] (as subject to adjustment hereunder, the "Warrant Shares") of registered common shares, nominal value CHF 0.02 per share (each, a "Common Share"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Auris Medical AG – COMMON SHARE PURCHASE WARRANT AURIS MEDICAL Holding Ag (July 3rd, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on June 18, 2020 (the "Termination Date") but not thereafter, to subscribe for and purchase from Auris Medical Holding AG, a company established in Switzerland (the "Company"), up to [______] (as subject to adjustment hereunder, the "Warrant Shares") of registered common shares, nominal value CHF 0.02 per share (each, a "Common Share"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Summit Semiconductor Inc. – Common Units Purchase Warrant Summit Semiconductor, Llc (July 2nd, 2018)

THIS COMMON UNITPURCHASE WARRANT (the "Warrant") certifies that, for value received [*] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement between the Company and the Holder (the "Purchase Agreement"), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Summit Semiconductor, LLC, a Delaware limited liability company (the "Company"), up to [*] Common Units (as subject to adjustment hereunder, the "Warrant Units"); provided, however, the number of Warrant Units exercisable pursuant to this Warrant shall double in the event the Company does not consummate an IPO by June 1, 2017. The purchase price of one Common Unit under this Warrant shall be equal to the Exercise Price, as defined in Section

Summit Semiconductor Inc. – Common Units Purchase Warrant Summit Semiconductor, Llc (July 2nd, 2018)

THIS COMMON UNIT PURCHASE WARRANT (the "Warrant") certifies that, for value received _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement between the Company and the Holder (the "Purchase Agreement"), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Summit Semiconductor, LLC, a Delaware limited liability company (the "Company"), up to __________ Common Units (as subject to adjustment hereunder, the "Warrant Units"). The purchase price of one Common Unit under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Summit Semiconductor Inc. – Common Units Purchase Warrant Summit Semiconductor, Llc (July 2nd, 2018)

THIS COMMON UNIT PURCHASE WARRANT (the "Warrant") certifies that, for value received MARCorp Signal, LLC or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement between the Company and the purchasers, including the Holder (the "Purchase Agreement"), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Summit Semiconductor, LLC, a Delaware limited liability company (the "Company"), up to that number of Common Units equal to the quotient of (x) the aggregate Principal Amount of the Note (as defined below) divided by (y) the Exercise Price (as defined below) (such number of Common Units to be subject to adjustment hereunder, the "Warrant Units"); provided, however, the number of Warrant Units exerci

Vascular Biogenics Ltd. – FORM OF [SERIES a/Series B] ORDINARY SHARE PURCHASE WARRANT Vascular Biogenics Ltd. (June 27th, 2018)

THIS [SERIES A/SERIES B] ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on ______________1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Vascular Biogenics Ltd., a company organized under the laws of Israel (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Ordinary Shares, NIS 0.01 par value (the "Ordinary Share(s)"), of the Company. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – SERIES B COMMON SHARE PURCHASE WARRANT Stellar Biotechnologies, Inc. (May 30th, 2018)

THIS SERIES B COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on May 29, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – SERIES a COMMON SHARE PURCHASE WARRANT Stellar Biotechnologies, Inc. (May 30th, 2018)

THIS SERIES A COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on May 29, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – SERIES a COMMON SHARE PURCHASE WARRANT Stellar Biotechnologies, Inc. (May 30th, 2018)

THIS SERIES A COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on May 29, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Retrospettiva Inc – PURCHASE WARRANT Issued To: Paulson Investment Company, LLC Exercisable to Purchase 147,267 Shares of Common Stock Of (May 24th, 2018)

This is to certify that, for value received and subject to the terms and conditions set forth below, the Warrantholder is entitled to purchase, and the Company promises and agrees to sell and issue to the Warrantholder, at any time on or after the Initial Exercise Date and on or before the Expiration Date, up to 147,267 shares of Common Stock at the per share Exercise Price.

Entera Bio Ltd. – Ordinary Share Purchase Warrant Entera Bio Ltd. (May 17th, 2018)

THIS ORDINARY SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, Cede & Co. or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ ], 2018 (the "Initial Exercise Date") and on or prior to 5:00 p.m., New York City time, on the fifth (5) year anniversary of the Initial Exercise Date, subject to early acceleration as set forth in Section 3(h) below (the "Termination Date") but not thereafter, to subscribe for and purchase from Entera Bio Ltd., a company limited by shares incorporated under the laws of Israel (the "Company"), up to [_______] Ordinary Shares (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depo

Stellar Biotechnologies, Inc. – COMMON SHARE PURCHASE WARRANT Stellar Biotechnologies, Inc. (May 15th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on May 15, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – COMMON SHARE PURCHASE WARRANT Stellar Biotechnologies, Inc. (May 15th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on May 10, 2023 (the "Termination Date"), provided that, if such date is not a Trading Day, the Termination Date should be the immediately following Trading Day but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – PRE-FUNDED COMMON SHARE PURCHASE WARRANT Stellar Biotechnologies, Inc. (May 15th, 2018)

THIS PRE-FUNDED COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") until this Warrant is exercised in full (the "Termination Date"), but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – Common Share Purchase Warrant Stellar Biotechnologies, Inc. (May 8th, 2018)

THIS COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on May __, 20231 (the "Termination Date"), provided that, if such date is not a Trading Day, the Termination Date should be the immediately following Trading Day but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Stellar Biotechnologies, Inc. – Pre-Funded Common Share Purchase Warrant Stellar Biotechnologies, Inc. (May 8th, 2018)

THIS PRE-FUNDED COMMON SHARE PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") until this Warrant is exercised in full (the "Termination Date"), but not thereafter, to subscribe for and purchase from Stellar Biotechnologies, Inc., a British Columbia corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common shares, no par value per share (the "Common Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).